The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cells.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMC 1440383)

Published in J Virol on April 01, 2006

Authors

Victor C Chu1, Lisa J McElroy, Vicky Chu, Beverley E Bauman, Gary R Whittaker

Author Affiliations

1: Dept. of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.

Associated clinical trials:

PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine | NCT04353037

Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients. (SeCOVID) | NCT04869579

Articles citing this

Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol (2008) 5.26

Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem (2009) 2.99

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A (2009) 1.83

Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J Virol (2006) 1.61

Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses (2012) 1.55

Lipids as modulators of membrane fusion mediated by viral fusion proteins. Eur Biophys J (2007) 1.29

Proteolytic activation of the spike protein at a novel RRRR/S motif is implicated in furin-dependent entry, syncytium formation, and infectivity of coronavirus infectious bronchitis virus in cultured cells. J Virol (2009) 1.13

Protease-mediated entry via the endosome of human coronavirus 229E. J Virol (2008) 1.09

Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry. J Virol (2007) 1.04

Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronaviruses. Vet Microbiol (2008) 0.99

Differential sensitivity of well-differentiated avian respiratory epithelial cells to infection by different strains of infectious bronchitis virus. J Virol (2010) 0.89

Unconventional use of LC3 by coronaviruses through the alleged subversion of the ERAD tuning pathway. Viruses (2011) 0.85

SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Virology (2009) 0.82

The infection of primary avian tracheal epithelial cells with infectious bronchitis virus. Vet Res (2009) 0.82

Pathogenesis and Diagnostic Approaches of Avian Infectious Bronchitis. Adv Virol (2016) 0.81

Fusion of Enveloped Viruses in Endosomes. Traffic (2016) 0.80

Feline aminopeptidase N is not a functional receptor for avian infectious bronchitis virus. Virol J (2007) 0.79

Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines. Viruses (2016) 0.78

Genome-Wide Screen Reveals Valosin-Containing Protein Requirement for Coronavirus Exit from Endosomes. J Virol (2015) 0.75

Articles cited by this

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03

HIV entry and its inhibition. Cell (1998) 9.42

Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem (2001) 8.96

HIV-1 inhibition by a peptide. Nature (1993) 5.01

Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell (2000) 4.88

Severe acute respiratory syndrome. Nat Med (2004) 4.75

The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol (2003) 4.21

The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol (2005) 4.19

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A (2005) 4.07

The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol (2003) 3.71

Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J Gen Virol (1990) 3.59

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A (2004) 3.03

Coronavirus spike proteins in viral entry and pathogenesis. Virology (2001) 2.85

Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J Virol (2002) 2.78

Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol (1990) 2.21

Fusion of Rous sarcoma virus with host cells does not require exposure to low pH. J Virol (1990) 1.97

Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci U S A (2004) 1.89

Mechanisms of pH regulation in the regulated secretory pathway. J Biol Chem (2001) 1.87

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet (2004) 1.87

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci U S A (2005) 1.85

Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8. J Virol (2003) 1.79

Imaging individual retroviral fusion events: from hemifusion to pore formation and growth. Proc Natl Acad Sci U S A (2005) 1.71

SARS-associated coronavirus. N Engl J Med (2003) 1.69

SFV infection in CHO cells: cell-type specific restrictions to productive virus entry at the cell surface. J Cell Sci (1997) 1.64

The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH. J Virol (2003) 1.63

The influenza hemagglutinin precursor as an acid-sensitive probe of the biosynthetic pathway. EMBO J (1987) 1.54

Activation of vesicular stomatitis virus fusion with cells by pretreatment at low pH. J Biol Chem (1988) 1.45

Receptor-induced conformational changes of murine coronavirus spike protein. J Virol (2002) 1.39

Coronavirus IBV: removal of spike glycopolypeptide S1 by urea abolishes infectivity and haemagglutination but not attachment to cells. J Gen Virol (1986) 1.39

Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion. J Virol (1990) 1.37

Reversibility in fusion protein conformational changes. The intriguing case of rhabdovirus-induced membrane fusion. Subcell Biochem (2000) 1.33

Dimer formation from 1-amino-8-naphthalenesulfonate catalyzed by bovine serum albumin. A new fluorescent molecule with exceptional binding properties. Biochemistry (1969) 1.32

Cellular entry of the SARS coronavirus. Trends Microbiol (2004) 1.29

Vesicular stomatitis virus G protein acquires pH-independent fusion activity during transport in a polarized endometrial cell line. J Virol (1999) 1.25

Monoclonal antibodies to the peplomer glycoprotein of coronavirus mouse hepatitis virus identify two subunits and detect a conformational change in the subunit released under mild alkaline conditions. J Virol (1990) 1.25

Quaternary structure of coronavirus spikes in complex with carcinoembryonic antigen-related cell adhesion molecule cellular receptors. J Biol Chem (2002) 1.23

Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site. J Virol (2004) 1.23

Probe transfer with and without membrane fusion in a fluorescence fusion assay. Biochemistry (1998) 1.09

Studies on the diagnosis of Newcastle disease and infectious bronchitis. IV. The use of the serum neutralization test in the diagnosis of infectious bronchitis. Cornell Vet (1951) 1.01

The coronavirus transmissible gastroenteritis virus causes infection after receptor-mediated endocytosis and acid-dependent fusion with an intracellular compartment. J Virol (1998) 1.00

Studies on avian infectious bronchitis virus (IBV). II. Propagation of IBV in several cultured cells. Arch Virol (1979) 0.94

Fluorescence assays to monitor fusion of enveloped viruses. Methods Enzymol (1993) 0.91

Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy. BMC Microbiol (2003) 0.91

Production and characterization of monoclonal antibodies to three infectious bronchitis virus serotypes. Avian Dis (1993) 0.90

pH-dependent binding of the fluorophore bis-ANS to influenza virus reflects the conformational change of hemagglutinin. Eur Biophys J (1994) 0.87

Coronavirus IBV-induced membrane fusion occurs at near-neutral pH. Arch Virol (1992) 0.82

Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions. Biochim Biophys Acta (2005) 0.80

Kinetic modeling of Sendai virus fusion with PC-12 cells. Effect of pH and temperature on fusion and viral inactivation. Eur J Biochem (1992) 0.79

Analysis of cell fusion induced by bovine coronavirus infection. Arch Virol (1988) 0.78

Articles by these authors

Dissecting virus entry via endocytosis. J Gen Virol (2002) 3.74

Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J Virol (2002) 2.78

Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic (2003) 2.47

Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology (2005) 2.24

Rab GTPases are recruited to chlamydial inclusions in both a species-dependent and species-independent manner. Infect Immun (2003) 2.10

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A (2009) 1.83

Influenza virus entry and infection require host cell N-linked glycoprotein. Proc Natl Acad Sci U S A (2004) 1.71

The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic (2003) 1.65

Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses (2012) 1.55

Role for influenza virus envelope cholesterol in virus entry and infection. J Virol (2003) 1.47

Bioinformatic and comparative localization of Rab proteins reveals functional insights into the uncharacterized GTPases Ypt10p and Ypt11p. Mol Cell Biol (2006) 1.26

Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein. J Biol Chem (2007) 1.25

Role of protein kinase C betaII in influenza virus entry via late endosomes. J Virol (2003) 1.22

Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus. J Virol (2010) 1.19

Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J Virol (2009) 1.18

Role of the actin cytoskeleton during influenza virus internalization into polarized epithelial cells. Cell Microbiol (2007) 1.11

Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion. Viruses (2012) 1.07

Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities. J Virol (2012) 1.06

Nucleo-cytoplasmic localization of influenza virus nucleoprotein depends on cell density and phosphorylation. Virus Res (2002) 1.02

Heparan sulfate is a selective attachment factor for the avian coronavirus infectious bronchitis virus Beaudette. Avian Dis (2007) 1.02

Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronaviruses. Vet Microbiol (2008) 0.99

Mutation in spike protein cleavage site and pathogenesis of feline coronavirus. Emerg Infect Dis (2013) 0.98

Utilization of DC-SIGN for entry of feline coronaviruses into host cells. J Virol (2008) 0.96

A novel activation mechanism of avian influenza virus H9N2 by furin. J Virol (2013) 0.93

Influenza virus-membrane fusion triggered by proton uncaging for single particle studies of fusion kinetics. Anal Chem (2012) 0.91

Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain. J Biol Chem (2010) 0.90

Entry of influenza virus. Adv Exp Med Biol (2013) 0.87

Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12. J Biol Chem (2013) 0.87

Feline lectin activity is critical for the cellular entry of feline infectious peritonitis virus. J Virol (2010) 0.86

Plasmin-mediated activation of pandemic H1N1 influenza virus hemagglutinin is independent of the viral neuraminidase. J Virol (2013) 0.86

Single particle assay of coronavirus membrane fusion with proteinaceous receptor-embedded supported bilayers. Biomaterials (2013) 0.85

Activation of p38 MAPK by feline infectious peritonitis virus regulates pro-inflammatory cytokine production in primary blood-derived feline mononuclear cells. Virology (2008) 0.85

Promotion of vesicular stomatitis virus fusion by the endosome-specific phospholipid bis(monoacylglycero)phosphate (BMP). FEBS Lett (2011) 0.85

Characterization of a recombinant canine coronavirus with a distinct receptor-binding (S1) domain. Virology (2012) 0.83

SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Virology (2009) 0.82

Feline aminopeptidase N is not a functional receptor for avian infectious bronchitis virus. Virol J (2007) 0.79

Expression of the C-type lectins DC-SIGN or L-SIGN alters host cell susceptibility for the avian coronavirus, infectious bronchitis virus. Vet Microbiol (2012) 0.79

Entry of rhabdoviruses into animal cells. Adv Exp Med Biol (2013) 0.78

Fluorescence dequenching assays of coronavirus fusion. Adv Exp Med Biol (2006) 0.78

Avian infectious bronchitis virus enters cells via the endocytic pathway. Adv Exp Med Biol (2006) 0.77

Acquisition of a novel eleven amino acid insertion directly N-terminal to a tetrabasic cleavage site confers intracellular cleavage of an H7N7 influenza virus hemagglutinin. Virology (2012) 0.77

Internalization and fusion mechanism of vesicular stomatitis virus and related rhabdoviruses. Future Virol (2010) 0.75

Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles. bioRxiv (2020) 0.75